Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03782298 · ClinicalTrials.gov registry record
Safety and Performance of PEEK Anchors in Extremities
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 140
- Enrollment target
NCT03782298: Completed study, sponsored by Smith & Nephew.
NCT03782298 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03782298 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
Safety and performance of the study devices in extremities up to 12 months post-surgery
Primary Outcome
Clinical success was defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon. Specifically, clinical success was considered "Yes" based on the following 3 main criteria: * no inflammatory or allergic response * no device-related adverse event (AE) * no device deficiencies (DDs) leading to revision surgery (re intervention) on the index extremity
Interventions
- DEVICE Spyromite, Dynomite, Raptomite, Footprint Ultra PK SL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2019-03-12 |
| Est. Completion | 2019-10-10 |
What the finished NCT03782298 record still lists
NCT03782298 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Spyromite, Dynomite, Raptomite, Footprint Ultra PK SL is the first listed.
NCT03782298 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03782298 about?
NCT03782298 is a clinical study titled "Safety and Performance of PEEK Anchors in Extremities". Safety and performance of the study devices in extremities up to 12 months post-surgery
What is the current status of trial NCT03782298?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2019-03-12. Estimated completion is 2019-10-10.
What interventions are being tested in trial NCT03782298?
The interventions under investigation include: Spyromite, Dynomite, Raptomite, Footprint Ultra PK SL (DEVICE).
Who is sponsoring clinical trial NCT03782298?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI